Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection
Wenjing Zai(Shanghai Medical College of Fudan University), Zhenghong Yuan(Shanghai Medical College of Fudan University), Min Jae Yang(Yanbian University of Science and Technology), Jieliang Chen(Shanghai Medical College of Fudan University), Changyou Zhan(Shanghai Medical College of Fudan University), Kongying Hu(Fudan University), Kuan Jiang(Sun Yat-sen University), Huijing Wang(Shanghai University), Chao Huang(Zhongyuan University of Technology), Juan Guan(Fudan University), Wei Fu(Sichuan University)
Cited by 30
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
|Protein & Cell|2020|397
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect
|Journal of Controlled Release|2010|365